The effect and mechanism of miR-30e-5p targeting SNAI1 to regulate epithelial-mesenchymal transition on pancreatic cancer

References

• Tempero MA, Malafa MP, Chiorean EG, et al. Pancreatic adenocarcinoma, version 1. J Natl Compr Canc Netw. 2019;17(3):202–210.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta oncologica. 2016;55(9–10):1158–1160.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA: A Cancer J Clin. 2020; 70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Mizrahi JD, Surana R, Valle JW, et al. Pancreatic cancer. Lancet. 2020;395(10242):2008–2020.
   PubMed Web of Science ®Google Scholar
• Peng JF, Zhuang YY, Huang FT, et al. Noncoding RNAs and pancreatic cancer. World J Gastroenterol. 2016;22(2):801–814.
   PubMed Web of Science ®Google Scholar
• Wang WT, Han C, Sun YM, et al. Noncoding RNAs in cancer therapy resistance and targeted drug development. J Hematol Oncol. 2019;12(1):55.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Shirjang S, et al. Micro-RNAs: the new potential biomarkers in cancer diagnosis, prognosis and cancer therapy. Cell Mol Biol. 2015;61(5):1–10.
   PubMed Web of Science ®Google Scholar
• Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Jama. 2007;297(17):1901–1908.
   PubMed Web of Science ®Google Scholar
• Mao J, Hu X, Pang P, et al. miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway. Oncol Rep. 2017;38(1):393–401.
   PubMed Web of Science ®Google Scholar
• Laudato S, Patil N, Abba ML, et al. P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1. Int J Cancer. 2017;141(9):1879–1890.
   PubMed Web of Science ®Google Scholar
• Ma Z, Chao F, Wang S, et al. CTHRC1 affects malignant tumor cell behavior and is regulated by miR-30e-5p in human prostate cancer. Biochem Biophys Res Commun. 2020;525(2):418–424.
   PubMed Web of Science ®Google Scholar
• Cinpolat O, Unal ZN, Ismi O, et al. Comparison of microRNA profiles between benign and malignant salivary gland tumors in tissue, blood and saliva samples: a prospective, case-control study. Braz J Otorhinolaryngol. 2017;83(3):276–284.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890.
   PubMed Web of Science ®Google Scholar
• Marcucci F, Stassi G, De Maria R. Epithelial-mesenchymal transition: a new target in anticancer drug discovery. Nat Rev Drug Discov. 2016;15(5):311–325.
   PubMed Web of Science ®Google Scholar
• Wang S, Huang S, Sun YL. Epithelial-Mesenchymal transition in pancreatic cancer: a review. Biomed Res Int. 2017;2017:2646148.
   PubMed Web of Science ®Google Scholar
• Hu J, Li L, Chen H, et al. MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma. Cell Death Dis. 2018;9(8):807.
   PubMedGoogle Scholar
• Li M, Wu P, Yang Z, et al. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. Am J Cancer Res. 2020;10(1):38–59.
   PubMed Web of Science ®Google Scholar
• Xue L, Shen Y, Zhai Z. Zheng S. miR539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1. Int J Mol Med. 2020;45(6):1771–1782.
   PubMed Web of Science ®Google Scholar
• Chen S, Xu J, Su Y, et al. MicroRNA-145 suppresses epithelial to mesenchymal transition in pancreatic cancer cells by inhibiting TGF-beta signaling pathway. J Cancer. 2020;11(9):2716–2723.
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen Z, Peng M, et al. MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3. Bioengineered. 2022;13(2):2673–2685.
   PubMed Web of Science ®Google Scholar
• Zhong X, Cai Y. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway. Bioengineered. 2021;12(2):9113–9127.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Jiang K, Zou H. microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1. Bioengineered. 2022;13(1):917–929.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang L, Chen W, et al. miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase. Bioengineered. 2021;12(1):6201–6209.
   PubMed Web of Science ®Google Scholar
• Kukurba KR, Montgomery SB. RNA sequencing and analysis. Cold Spring Harb Protoc. 2015;2015(11):951–969.
   PubMedGoogle Scholar
• Hong M, Tao S, Zhang L, et al. RNA sequencing: new technologies and applications in cancer research. J Hematol Oncol. 2020;13(1):166.
   PubMed Web of Science ®Google Scholar
• Pertea M, Kim D, Pertea GM, et al. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc. 2016;11(9):1650–1667.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42( Database issue):D92–7.
   PubMed Web of Science ®Google Scholar
• Wang F, Gu T, Chen Y, et al. Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis. Bioengineered. 2021;12(1):6724–6737.
   PubMed Web of Science ®Google Scholar
• Kwon JJ, Factora TD, Dey S, et al. A systematic review of miR-29 in cancer. Mol Ther Oncolytics. 2019;12:173–194.
   PubMed Web of Science ®Google Scholar
• Haneklaus M, Gerlic M, O’Neill LA. Masters SL. miR-223: infection, inflammation and cancer. J Intern Med. 2013;274(3):215–226.
   PubMed Web of Science ®Google Scholar
• Zhang S, Li G, Liu C, et al. miR-30e-5p represses angiogenesis and metastasis by directly targeting AEG-1 in squamous cell carcinoma of the head and neck. Cancer Sci. 2020;111(2):356–368.
   PubMed Web of Science ®Google Scholar
• Xu G, Cai J, Wang L, et al. MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling. Exp Cell Res. 2018;362(2):268–278.
   PubMed Web of Science ®Google Scholar
• Xu K, Zhang P, Zhang J, et al. Identification of potential micro-messenger RNAs (miRNA-mRNA) interaction network of osteosarcoma. Bioengineered. 2021;12(1):3275–3293.
   PubMed Web of Science ®Google Scholar
• Nambiar D, Prajapati V, Agarwal R, et al. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells. Cancer Lett. 2013;334(1):109–117.
   PubMed Web of Science ®Google Scholar
• Tang L, Chen Y, Chen H, et al. DCST1-AS1 promotes TGF-beta-Induced Epithelial-Mesenchymal transition and enhances chemoresistance in triple-negative breast cancer cells via ANXA1. Front Oncol. 2020;10:280.
   PubMed Web of Science ®Google Scholar
• Deep G, Jain AK, Ramteke A, et al. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin. Mol Cancer. 2014;13:37.
   PubMed Web of Science ®Google Scholar
• Dong Y, Sun X, Zhang K, et al. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression. Bioengineered. 2021;12(2):12967–12979.
   PubMed Web of Science ®Google Scholar
• Shields MA, Ebine K, Sahai V, et al. Snail cooperates with KrasG12D to promote pancreatic fibrosis. Mol Cancer Res. 2013;11(9):1078–1087.
   PubMed Web of Science ®Google Scholar
• Mikami S, Katsube K, Oya M, et al. Expression of snail and slug in renal cell carcinoma: e-cadherin repressor snail is associated with cancer invasion and prognosis. Lab Invest. 2011;91(10):1443–1458.
   PubMed Web of Science ®Google Scholar
• Cai J. Roles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma. Exp Ther Med. 2013;6(6):1489–1493.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196.
   PubMed Web of Science ®Google Scholar